Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis
Author
dc.contributor.author
Núñez Figueroa, Paulina Javiera
Author
dc.contributor.author
Cleveland, Noa Krugliak
Author
dc.contributor.author
Quera Pino, Rodrigo Enrique
Author
dc.contributor.author
Rubín, David T.
Admission date
dc.date.accessioned
2021-11-05T14:24:20Z
Available date
dc.date.available
2021-11-05T14:24:20Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
World J Gastroenterol 2021 May 28; 27(20): 2521-2530
es_ES
Identifier
dc.identifier.other
10.3748/wjg.v27.i20.2521
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/182614
Abstract
dc.description.abstract
Inflammatory bowel disease, encompassing Crohn’s disease (CD) and ulcerative
colitis, are chronic immune-mediated inflammatory bowel diseases (IBD) that
primarily affect the gastrointestinal tract with periods of activity and remission.
Large body of evidence exist to strengthen the prognostic role of endoscopic
evaluation for both disease activity and severity and it remains the gold standard
for the assessment of mucosal healing. Mucosal healing has been associated with
improved clinical outcomes with prolonged remission, decreased hospitalization,
IBD-related surgeries and colorectal cancer risk. Therefore, endoscopic objectives
in IBD have been incorporated as part of standard care. With the known increased
risk of colorectal cancer in IBD, although prevention strategies continue to
develop, regular surveillance for early detection of neoplasia continue to be
paramount in IBD patients’ care. It is thanks to evolving technology and visualization
techniques that surveillance strategies are continuously advancing.
Therapeutic endoscopic options in IBD have also been expanding, from surgery
sparing therapies such as balloon dilation of fibrostenotic strictures in CD to
endoscopic mucosal resection of neoplastic lesions. In this review article, we
discuss the current evidence on the use of endoscopy as part of standard of care of
IBD, its role in surveillance of neoplasia, and the role of interventional endoscopic
therapies.
es_ES
Patrocinador
dc.description.sponsorship
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) P30 DK042086
Origen de datos de financiación:Medline
Aparece en contenido como:NIDDK NIH HHS
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
Baishideng Publishing Group Inc, United States
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States